Graphene Investments SAS Has $3.04 Million Stake in Bath & Body Works, Inc. (NYSE:BBWI)

Graphene Investments SAS reduced its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 15.9% during the 4th quarter, Holdings Channel.com reports. The firm owned 78,400 shares of the company’s stock after selling 14,800 shares during the period. Bath & Body Works accounts for 2.1% of Graphene Investments SAS’s investment portfolio, making the stock its 16th biggest position. Graphene Investments SAS’s holdings in Bath & Body Works were worth $3,040,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. FMR LLC boosted its holdings in shares of Bath & Body Works by 17,496.5% during the third quarter. FMR LLC now owns 2,516,127 shares of the company’s stock worth $80,315,000 after purchasing an additional 2,501,828 shares during the period. KBC Group NV lifted its position in Bath & Body Works by 9,023.5% in the 3rd quarter. KBC Group NV now owns 1,701,813 shares of the company’s stock worth $54,322,000 after buying an additional 1,683,160 shares in the last quarter. Erste Asset Management GmbH acquired a new stake in shares of Bath & Body Works during the 3rd quarter valued at $50,483,000. Forest Avenue Capital Management LP grew its holdings in shares of Bath & Body Works by 19.1% during the 3rd quarter. Forest Avenue Capital Management LP now owns 1,467,763 shares of the company’s stock valued at $46,851,000 after acquiring an additional 235,173 shares in the last quarter. Finally, Verition Fund Management LLC increased its stake in shares of Bath & Body Works by 111.8% in the third quarter. Verition Fund Management LLC now owns 1,345,777 shares of the company’s stock worth $42,957,000 after acquiring an additional 710,333 shares during the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. Wells Fargo & Company upgraded Bath & Body Works from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $42.00 to $48.00 in a research note on Friday, January 10th. TD Cowen raised their price target on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a report on Thursday, December 12th. Morgan Stanley decreased their price objective on shares of Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a report on Thursday, November 21st. Deutsche Bank Aktiengesellschaft boosted their price target on Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Finally, Piper Sandler upped their target price on Bath & Body Works from $36.00 to $39.00 and gave the stock a “neutral” rating in a research report on Monday, January 6th. One analyst has rated the stock with a sell rating, six have given a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $43.19.

Bath & Body Works Stock Performance

NYSE BBWI opened at $37.41 on Friday. Bath & Body Works, Inc. has a twelve month low of $26.20 and a twelve month high of $52.99. The stock has a market cap of $8.10 billion, a PE ratio of 9.12, a PEG ratio of 1.01 and a beta of 1.83. The firm has a 50-day simple moving average of $37.75 and a 200 day simple moving average of $33.67.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Monday, November 25th. The company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.46 by $0.03. The company had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.58 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. Bath & Body Works’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same quarter last year, the firm earned $0.48 EPS. Research analysts forecast that Bath & Body Works, Inc. will post 3.26 earnings per share for the current fiscal year.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.